These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37438822)

  • 1. Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes.
    Bauer K; Rosenow F; Knake S; Willems LM; Kämppi L; Strzelczyk A
    Neurol Res Pract; 2023 Jul; 5(1):34. PubMed ID: 37438822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes.
    Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S
    J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.
    Kortland LM; Knake S; von Podewils F; Rosenow F; Strzelczyk A
    Front Neurol; 2017; 8():507. PubMed ID: 29018404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
    Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
    Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience.
    Llauradó A; Campos D; Quintana M; Ballvé A; Fonseca E; Abraira L; Giffreu A; Toledo M; Santamarina E
    Epilepsy Res; 2022 Sep; 185():106988. PubMed ID: 35907324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
    Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
    J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data.
    Schubert-Bast S; Zöllner JP; Ansorge S; Hapfelmeier J; Bonthapally V; Eldar-Lissai A; Rosenow F; Strzelczyk A
    Epilepsia; 2019 May; 60(5):911-920. PubMed ID: 30980677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-refractory status epilepticus in West China.
    Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D
    Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of outcome in refractory status epilepticus.
    Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
    JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review.
    Specchio N; Auvin S; Strzelczyk A; Brigo F; Villanueva V; Trinka E
    Epilepsia Open; 2024 Dec; 9(6):2017-2036. PubMed ID: 39360600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
    Takeuchi H; Higurashi N; Toga Y
    Brain Dev; 2024 Jun; 46(6):219-223. PubMed ID: 38519270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.
    Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F
    Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and cost-driving factors of acute treatment of status epilepticus in children and adolescents: A cohort study from Germany.
    Schubert-Bast S; Lenders C; Kieslich M; Rosenow F; Strzelczyk A
    Seizure; 2022 Apr; 97():63-72. PubMed ID: 35344919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
    Hubert K; Knake S; Bauer S; Voss M; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2020 Aug; 109():107139. PubMed ID: 32417381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.
    Kortland LM; Alfter A; Bähr O; Carl B; Dodel R; Freiman TM; Hubert K; Jahnke K; Knake S; von Podewils F; Reese JP; Runge U; Senft C; Steinmetz H; Rosenow F; Strzelczyk A
    Epilepsia; 2016 Dec; 57(12):2056-2066. PubMed ID: 27753082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.
    Kantanen AM; Sairanen J; Kälviäinen R
    Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.